The National Psoriasis Foundation (NPF) is proud to host the second year of the Payer Education Program. This program is designed to increase payers’ knowledge of psoriasis (PsO) and psoriatic arthritis (PsA), together called psoriatic disease, the impacts of the disease, and the importance of access to all appropriate treatments.
Patients with complex and chronic diseases such as psoriatic disease often need high-cost specialty medications to manage their conditions and maintain their overall health. Left under-managed or untreated, psoriatic disease can lead to life-long physical and emotional impacts on individuals, as well as significant economic burdens.
This free program will provide the information you need to guide decision making around treatments and formularies.
Led by Dr. Junko Takeshita, Assistant Professor, University of Pennsylvania, with Leah Howard, J.D., President and CEO of NPF, this program will cover:
- PsO as a systemic disease and differentiation from other inflammatory skin conditions
- PsA, including the early signs of joint involvement in PsO
- The role of insurers in supporting improved health outcomes
- The burden of psoriatic disease beyond the skin, including associated comorbid conditions and psychosocial effects
- The pathogenesis of psoriatic disease, including the mechanisms of action of current treatment options and Treat to Target goals
- The complexities of PsO in Skin of Color and other special populations